Spanish researchers reported the results of a new study showing that contact lenses (CLs) soaked in melatonin and melatonin analogue solutions could be used to treat aqueous tear deficient dry eye disease (DED).
US researchers improved symptoms in severe dry eye disease (DED) sufferers using a lubricant derived from cultured stem cells from the corneoscleral rim of cadavers.
Researchers evaluating the effects of oral supplements of caffeine metabolite 7-methylxanthine (7-MX) have found it reduces the rate of axial length increase in myopic children. Although 7-MX has
US scientists have developed a contact lens (CL) which may help with the early detection of cancer by examining tears. Microchambers in the CL, developed at the Terasaki Institute for Biomedical
An independent clinical study confirmed EssilorLuxottica’s ClickCheck – an award-winning portable, low-cost and easy-to-use refractive device – has the capacity to enhance the efficiency of primary
A Taiwanese study has discovered that moderate to severe obstructive sleep apnoea (OSA) was more commonly associated with floppy eyelid syndrome, shorter tear breakup time and higher ocular redness scores than with normal to mild OSA.
It’s probably not too common to read the word ‘dragon’ in the same sentence as resilience… far less a purple one! But they are inextricably linked and, if you’ll bear with me, I’ll explain how.
Despite a 2014 commitment from the pharmaceutical industry to improve data transparency, more than half of the clinical trials leading to US Food and Drug Administration-approved anti-cancer medicines are not available for independent scrutiny, reported a Flinders University study.
The New Zealand Laser Training Institute is offering a new online training course focused on optometrists and others interested in treating dry eye.
The Royal New Zealand Foundation of the Blind (RNZFB) and partner Generus Living Group are well underway creating New Zealand’s first six-star retirement village, with construction of the first building due for completion later this year.
Researchers from New Zealand’s Lincoln and Otago Universities have developed a world-first treatment for Batten disease, which has been approved for human trials in the US.
The FDA has greenlit Staar Surgical’s EVO/EVO+ Visian Implantable Collamer lens for the correction of myopia and myopia with astigmatism.
